Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Letter

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Authors: Jonathan Rilinger, Winfried V. Kern, Daniel Duerschmied, Alexander Supady, Christoph Bode, Dawid L. Staudacher, Tobias Wengenmayer

Published in: Trials | Issue 1/2020

Login to get access
Metadata
Title
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Authors
Jonathan Rilinger
Winfried V. Kern
Daniel Duerschmied
Alexander Supady
Christoph Bode
Dawid L. Staudacher
Tobias Wengenmayer
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04447-3

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue